{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,24]],"date-time":"2025-11-24T06:50:14Z","timestamp":1763967014400,"version":"3.40.5"},"reference-count":29,"publisher":"American Academy of Pediatrics (AAP)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2006,3,1]]},"abstract":"<jats:p>In addition to increased susceptibility to infections in patients with chronic granulomatous disease (CGD), a higher incidence of sterile inflammatory disorders in these patients has been noted. However, sarcoidosis has not been reported previously in CGD. In this report, we describe two patients who have CGD and a disorder consistent with sarcoidosis on the basis of unequivocal clinical-radiographic presentations, their responses to treatment, and serum angiotensin-converting enzyme levels. Serum angiotensin-converting enzyme levels were measured in 26 other patients with CGD to establish an appropriate reference range. A possible relationship between CGD and sarcoidosis is discussed.<\/jats:p>","DOI":"10.1542\/peds.2005-1349","type":"journal-article","created":{"date-parts":[[2006,2,2]],"date-time":"2006-02-02T01:58:01Z","timestamp":1138845481000},"page":"e590-e595","source":"Crossref","is-referenced-by-count":33,"title":["Sarcoidosis in Chronic Granulomatous Disease"],"prefix":"10.1542","volume":"117","author":[{"given":"Suk See","family":"De Ravin","sequence":"first","affiliation":[{"name":"National Institute of Allergy and Infectious Diseases"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nora","family":"Naumann","sequence":"additional","affiliation":[{"name":"National Institute of Allergy and Infectious Diseases"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael R.","family":"Robinson","sequence":"additional","affiliation":[{"name":"National Eye Institute"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karyl S.","family":"Barron","sequence":"additional","affiliation":[{"name":"National Institute of Allergy and Infectious Diseases"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David E.","family":"Kleiner","sequence":"additional","affiliation":[{"name":"National Cancer Institute, National Institutes of Health, Bethesda, Maryland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean","family":"Ulrick","sequence":"additional","affiliation":[{"name":"National Institute of Allergy and Infectious Diseases"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julia","family":"Friend","sequence":"additional","affiliation":[{"name":"National Institute of Allergy and Infectious Diseases"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Victoria L.","family":"Anderson","sequence":"additional","affiliation":[{"name":"National Institute of Allergy and Infectious Diseases"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dirk","family":"Darnell","sequence":"additional","affiliation":[{"name":"National Institute of Allergy and Infectious Diseases"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizabeth M.","family":"Kang","sequence":"additional","affiliation":[{"name":"National Institute of Allergy and Infectious Diseases"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Harry L.","family":"Malech","sequence":"additional","affiliation":[{"name":"National Institute of Allergy and Infectious Diseases"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"417","published-online":{"date-parts":[[2006,3,1]]},"reference":[{"key":"2021120820104082700_R1","doi-asserted-by":"crossref","unstructured":"Winkelstein JA, Marino MC, Johnston RB Jr, et al. Chronic granulomatous disease. Report on a national registry of 368 patients. Medicine (Baltimore).\u20082000;79:155\u2013169","DOI":"10.1097\/00005792-200005000-00003"},{"key":"2021120820104082700_R2","doi-asserted-by":"crossref","unstructured":"Heyworth PG, Cross AR, Curnutte JT. Chronic granulomatous disease. Curr Opin Immunol.\u20082003;15:578\u2013584","DOI":"10.1016\/S0952-7915(03)00109-2"},{"key":"2021120820104082700_R3","doi-asserted-by":"crossref","unstructured":"Hoitsma E, Faber CG, Drent M, Sharma OP. Neurosarcoidosis: a clinical dilemma. Lancet Neurol.\u20082004;3:397\u2013407","DOI":"10.1016\/S1474-4422(04)00805-1"},{"key":"2021120820104082700_R4","unstructured":"Popper HH. Epithelioid cell granulomatosis of the lung: new insights and concepts. Sarcoidosis Vasc Diffuse Lung Dis.\u20081999;16:32\u201346"},{"key":"2021120820104082700_R5","doi-asserted-by":"crossref","unstructured":"Newman LS, Rose CS, Maier LA. Sarcoidosis. N Engl J Med.\u20081997;336:1224\u20131234","DOI":"10.1056\/NEJM199704243361706"},{"key":"2021120820104082700_R6","doi-asserted-by":"crossref","unstructured":"Nunes H, Soler P, Valeyre D. Pulmonary sarcoidosis. Allergy.\u20082005;60:565\u2013582","DOI":"10.1111\/j.1398-9995.2005.00778.x"},{"key":"2021120820104082700_R7","doi-asserted-by":"crossref","unstructured":"Schnabel A, Barth J, Schubert F, Gross WL. Pulmonary sarcoidosis coexisting with systemic lupus erythematosus. Scand J Rheumatol.\u20081996;25:109\u2013111","DOI":"10.3109\/03009749609069219"},{"key":"2021120820104082700_R8","unstructured":"Fivenson DP, Crump G, Scheele P, Breneman DL. Systemic lupus erythematosus developing in a patient with longstanding pulmonary sarcoidosis. J Rheumatol.\u20081989;16:1116\u20131119"},{"key":"2021120820104082700_R9","unstructured":"Begum S, Li C, Wedderburn LR, Blackwell V, Isenberg DA. Concurrence of sarcoidosis and systemic lupus erythematosus in three patients. Clin Exp Rheumatol.\u20082002;20:549\u2013552"},{"key":"2021120820104082700_R10","doi-asserted-by":"crossref","unstructured":"Shorr AF, Torrington KG, Parker JM. Serum angiotensin converting enzyme does not correlate with radiographic stage at initial diagnosis of sarcoidosis. Respir Med.\u20081997;91:399\u2013401","DOI":"10.1016\/S0954-6111(97)90252-3"},{"key":"2021120820104082700_R11","doi-asserted-by":"crossref","unstructured":"Farrell AM, Henry K, Woodrow D, et al. Cutaneous granulomas associated with high-grade T-cell non-Hodgkin's lymphoma. Br J Dermatol.\u20081999;140:145\u2013149","DOI":"10.1046\/j.1365-2133.1999.02625.x"},{"key":"2021120820104082700_R12","doi-asserted-by":"crossref","unstructured":"Constantino T, Digre K, Zimmerman P. Neuro-ophthalmic complications of sarcoidosis. Semin Neurol.\u20082000;20:123\u2013137","DOI":"10.1055\/s-2000-6838"},{"key":"2021120820104082700_R13","doi-asserted-by":"crossref","unstructured":"Uyama M. Uveitis in sarcoidosis. Int Ophthalmol Clin.\u20082002;42:143\u2013150","DOI":"10.1097\/00004397-200201000-00018"},{"key":"2021120820104082700_R14","doi-asserted-by":"crossref","unstructured":"Goldblatt D, Butcher J, Thrasher AJ, Russell-Eggitt I. Chorioretinal lesions in patients and carriers of chronic granulomatous disease. J Pediatr.\u20081999;134:780\u2013783","DOI":"10.1016\/S0022-3476(99)70299-4"},{"key":"2021120820104082700_R15","doi-asserted-by":"crossref","unstructured":"Gelwan MJ, Kellen RI, Burde RM, Kupersmith MJ. Sarcoidosis of the anterior visual pathway: successes and failures. J Neurol Neurosurg Psychiatry.\u20081988;51:1473\u20131480","DOI":"10.1136\/jnnp.51.12.1473"},{"key":"2021120820104082700_R16","doi-asserted-by":"crossref","unstructured":"Hadfield MG, Ghatak NR, Laine FJ, Myer EC, Massie FS, Kramer WM. Brain lesions in chronic granulomatous disease. Acta Neuropathol (Berl).\u20081991;81:467\u2013470","DOI":"10.1007\/BF00293469"},{"key":"2021120820104082700_R17","doi-asserted-by":"crossref","unstructured":"Agus S, Spektor S, Israel Z. CNS granulomatosis in a child with chronic granulomatous disease. Br J Neurosurg.\u20082000;14:59\u201361","DOI":"10.1080\/02688690042951"},{"key":"2021120820104082700_R18","doi-asserted-by":"crossref","unstructured":"Kim SJ, Kim JG, Yu YS. Chorioretinal lesions in patients with chronic granulomatous disease. Retina.\u20082003;23:360\u2013365","DOI":"10.1097\/00006982-200306000-00012"},{"key":"2021120820104082700_R19","doi-asserted-by":"crossref","unstructured":"Whitsett CF, Merritt JC, Mower P, Daffin L. HLA-A, B and DR antigens in North Carolina blacks with sarcoidosis. Tissue Antigens.\u20081983;21:348\u2013350","DOI":"10.1111\/j.1399-0039.1983.tb00183.x"},{"key":"2021120820104082700_R20","doi-asserted-by":"crossref","unstructured":"Lynch JP 3rd. Neurosarcoidosis: how good are the diagnostic tests?J Neuroophthalmol.\u20082003;23:187\u2013189","DOI":"10.1097\/00041327-200309000-00001"},{"key":"2021120820104082700_R21","doi-asserted-by":"crossref","unstructured":"Hunninghake GW, Costabel U, Ando M, et al. ATS\/ERS\/WASOG statement on sarcoidosis. American Thoracic Society\/European Respiratory Society\/World Association of Sarcoidosis and other Granulomatous Disorders. Sarcoidosis Vasc Diffuse Lung Dis.\u20081999;16:149\u2013173","DOI":"10.1034\/j.1399-3003.1999.14d02.x"},{"key":"2021120820104082700_R22","doi-asserted-by":"crossref","unstructured":"Pueringer RJ, Schwartz DA, Dayton CS, Gilbert SR, Hunninghake GW. The relationship between alveolar macrophage TNF, IL-1, and PGE2 release, alveolitis, and disease severity in sarcoidosis. Chest.\u20081993;103:832\u2013838","DOI":"10.1378\/chest.103.3.832"},{"key":"2021120820104082700_R23","doi-asserted-by":"crossref","unstructured":"Tavares JL, Wangoo A, Dilworth P, Marshall B, Kotecha S, Shaw RJ. Thalidomide reduces tumour necrosis factor-alpha production by human alveolar macrophages. Respir Med.\u20081997;91:31\u201339","DOI":"10.1016\/S0954-6111(97)90134-7"},{"key":"2021120820104082700_R24","doi-asserted-by":"crossref","unstructured":"Baughman RP. Therapeutic options for sarcoidosis: new and old. Curr Opin Pulm Med.\u20082002;8:464\u2013469","DOI":"10.1097\/00063198-200209000-00021"},{"key":"2021120820104082700_R25","doi-asserted-by":"crossref","unstructured":"Baughman RP, Iannuzzi M. Tumour necrosis factor in sarcoidosis and its potential for targeted therapy. BioDrugs.\u20082003;17:425\u2013431","DOI":"10.2165\/00063030-200317060-00005"},{"key":"2021120820104082700_R26","doi-asserted-by":"crossref","unstructured":"Foster CB, Lehrnbecher T, Mol F, et al. Host defense molecule polymorphisms influence the risk for immune-mediated complications in chronic granulomatous disease. J Clin Invest.\u20081998;102:2146\u20132155","DOI":"10.1172\/JCI5084"},{"key":"2021120820104082700_R27","doi-asserted-by":"crossref","unstructured":"Warris A, Netea MG, Wang JE, et al. Cytokine release in healthy donors and patients with chronic granulomatous disease upon stimulation with Aspergillus fumigatus. Scand J Infect Dis.\u20082003;35:482\u2013487","DOI":"10.1080\/00365540310013009"},{"key":"2021120820104082700_R28","doi-asserted-by":"crossref","unstructured":"Hatanaka E, Carvalho BT, Condino-Neto A, Campa A. Hyperresponsiveness of neutrophils from gp 91phox deficient patients to lipopolysaccharide and serum amyloid A. Immunol Lett.\u20082004;94:43\u201346","DOI":"10.1016\/j.imlet.2004.04.016"},{"key":"2021120820104082700_R29","doi-asserted-by":"crossref","unstructured":"Jackson SH, Devadas S, Kwon J, Pinto LA, Williams MS. T cells express a phagocyte-type NADPH oxidase that is activated after T cell receptor stimulation. Nat Immunol.\u20082004;5:818\u2013827","DOI":"10.1038\/ni1096"}],"container-title":["Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/117\/3\/e590\/1070038\/zpe0030600e590.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/117\/3\/e590\/1070038\/zpe0030600e590.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,8]],"date-time":"2021-12-08T23:44:35Z","timestamp":1639007075000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.aap.org\/pediatrics\/article\/117\/3\/e590\/68563\/Sarcoidosis-in-Chronic-Granulomatous-Disease"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,3,1]]},"references-count":29,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2006,3,1]]},"published-print":{"date-parts":[[2006,3,1]]}},"URL":"https:\/\/doi.org\/10.1542\/peds.2005-1349","relation":{},"ISSN":["0031-4005","1098-4275"],"issn-type":[{"type":"print","value":"0031-4005"},{"type":"electronic","value":"1098-4275"}],"subject":[],"published":{"date-parts":[[2006,3,1]]}}}